Viewing Study NCT04887857

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2025-12-29 @ 9:41 AM
Study NCT ID: NCT04887857
Status: COMPLETED
Last Update Posted: 2024-02-12
First Post: 2021-05-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myeloid, Acute View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute Myeloid Leukemia View
None CC-486 View
None Onureg View
None oral azacitidine View
None venetoclax View
None Venclexta View
None Venclyxto View